General considerations in intermittent drug therapy of pulmonary tuberculosis
- PMID: 4110537
- PMCID: PMC2467339
- DOI: 10.1136/pgmj.47.553.729
General considerations in intermittent drug therapy of pulmonary tuberculosis
Abstract
The advantages of intermittent chemotherapy for pulmonary tuberculosis are discussed and the results of several controlled trials summarized. Once-weekly therapy now appears a definite prospect.
The most appropriate approach to therapy at both national and individual physician level now seems to be a combination of unsupervised daily and supervised intermittent regimens.
